Zentiva and Siyiara Enterprises have signed a shared purchase agreement to acquire Romania’s Solacium, together with its subsidiary Be Well Pharma. Food supplement and OTC medicines producer Solacium – which is currently part of the Dr. Max Group and owned by Siyiara along with Solacium’s general manager Alexandru-Tony Trasca – says it specializes in developing partnerships with healthcare specialists that are “based on delivering innovative products”.
Nick Haggar, Zentiva’s recently-appointed CEO, said that the company was “delighted to confirm the signing of its first acquisition following...
